Insider Holders & Insider Ownership - AGIOS PHARMACEUTICALS INC. (AGIO)

List of insiders holdings for AGIOS PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
CELGENE CORP
Celgene European Investment Co LLC
Celgene Switzerland LLC
Celgene Alpine Investment Co. LLC
10% Owner		2019-11-14 16:07:117,121,658
0		7,121,658Form 13D
STARR KEVIN P
Director
10% Owner		2015-02-19 19:01:33342,253
4,590,480		4,932,733Form 4
THIRD ROCK VENTURES LP
Third Rock Ventures GP L.P.
TRV GP LLC
10% Owner		2015-02-19 19:03:374,590,480
0		4,590,480Form 4
Flagship Ventures Fund 2007 L.P.
AFEYAN NOUBAR
KANIA EDWIN M JR
Flagship Ventures 2007 General Partner LLC
10% Owner		2017-02-13 14:25:03965,369
0		965,369Form 13G
Mak Tak W.
10% Owner		2013-07-23 20:23:06545,454
0		545,454Form 3
Schenkein David P
Director		2024-02-29 16:05:13180,325
349,854		530,179Form 4
Higgons John Duncan
Chief Operating Officer		2016-01-05 17:20:30483,035
0		483,035Form 4
Goff Brian
Chief Executive Officer		2024-03-05 16:10:31320,280
0		320,280Form 4
Cantley Lewis Clayton Jr.
Director		2017-12-08 16:23:4279,475
121,121		200,596Form 4
FOUSE JACQUALYN A
Director		2024-04-10 16:03:55153,329
0		153,329Form 4
Gheuens Sarah
Chief Medical Officer		2024-03-05 16:20:43127,899
0		127,899Form 4
Burns James William
Chief Legal Officer		2024-03-05 16:08:37126,002
0		126,002Form 4
Hoerter Steven L.
Chief Commercial Officer		2019-03-05 16:04:05117,241
0		117,241Form 4
NELSEN ROBERT
Director		2017-03-07 16:35:15109,230
0		109,230Form 4
Goddard Glenn
Senior Vice President, Finance		2016-02-18 17:15:42108,572
0		108,572Form 4
Jones Cecilia
Chief Financial Officer		2024-03-05 16:18:0895,840
0		95,840Form 4
Biller Scott
Chief Scientific Officer		2019-06-13 16:07:4233,729
53,059		86,788Form 4
Milanova Tsveta
Chief Commercial Officer		2024-03-05 16:06:3877,000
0		77,000Form 4
Car Bruce
Chief Scientific Officer		2022-03-03 16:11:4652,500
0		52,500Form 4
Biller Jonathan
Chief Financial Officer		2022-03-03 16:12:1952,500
0		52,500Form 4
Tessier-Lavigne Marc
Director		2016-06-23 16:10:1848,875
0		48,875Form 4
Owen Catherine E.
Director		2023-06-15 16:32:1539,106
0		39,106Form 4
CAPELLO JEFFREY D
Director		2023-06-15 16:30:4739,106
0		39,106Form 4
Hirsch Andrew
Chief Financial Officer		2020-04-24 16:06:3636,057
0		36,057Form 4
Clancy Paul J
Director		2022-06-23 16:09:4034,282
0		34,282Form 4
MARAGANORE JOHN
Director		2023-02-03 16:06:0328,528
0		28,528Form 5
KARSEN PERRY A
Director		2015-06-25 18:26:5323,125
0		23,125Form 4
Bowden Christopher
Chief Medical Officer		2021-06-22 16:44:1916,479
0		16,479Form 4
Scadden David
Director		2023-06-23 16:36:0212,095
0		12,095Form 4
Ho Maykin
Director		2023-06-23 16:37:2611,524
0		11,524Form 4
Poddar Richa
Chief Commercial Officer		2022-10-18 16:17:108508
0		8508Form 4
Foster-Cheek Kaye I
Director		2024-03-11 16:09:275524
2200		7724Form 4
Miles Darrin
Chief Commercial Officer		2021-05-18 16:11:407209
0		7209Form 4
Smith Cynthia
Director		2023-08-15 16:04:226906
0		6906Form 4
Ballal Rahul D.
Director		2023-08-15 16:06:446906
0		6906Form 4
CLARK IAN T
Director		2022-05-24 16:12:106549
0		6549Form 4
Cole Douglas G.
Director		2016-08-11 16:33:473695
0		3695Form 4
Alenson Carman
Principal Accounting Officer		2021-06-23 17:28:443555
0		3555Form 4
Washburn Theodore James Jr.
Principal Accounting Officer		2024-03-07 18:47:572886
0		2886Form 4
Arch Venture Fund VII LP
ARCH Venture Partners VII L.P.
ARCH Venture Partners VII LLC
CRANDELL KEITH
BYBEE CLINTON
10% Owner		2016-02-11 12:24:080
0		0Form 13G